(Q51099441)

English

Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results.

scientific article published on 29 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Determination of ANA specificity using multiplexed fluorescent microsphere immunoassay in patients with ANA positivity at high titres after infliximab treatment: preliminary results. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

1 reference

based on heuristic

inferred from title

author name string

Paola Caramaschi

1

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Orazio Ruzzenente

2

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Sara Pieropan

3

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Alessandro Volpe

4

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Antonio Carletto

5

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Lisa Maria Bambara

6

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Domenico Biasi

7

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

publication date

29 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Rheumatology International

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

27

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

7

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

649-654

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

https://scigraph.springernature.com/pub.10.1007/s00296-006-0271-8

0 references

Autoantibodies in the diagnosis of systemicrheumatic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00296-006-0271-8

21 January 2018

Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNFalpha therapy in rheumatoid arthritis and autoimmunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparability study of the emerging protein array platforms with established ELISA procedures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: safety of infliximab in clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab therapy in rheumatoid arthritis and ankylosing spondylitis-induced specific antinuclear and antiphospholipid autoantibodies without autoimmune clinical manifestations: a two-year prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of multiplexed fluorescent microsphere immunoassay for detection of autoantibodies to nuclear antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-TNF-alpha-induced systemic lupus syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-induced systemic lupus erythematosus and TNF-alpha blockers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infliximab-induced lupus in Crohn's disease: a case report.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A lupus-like syndrome associated with infliximab therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17136355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00296-006-0271-8

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17136355

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51099441&oldid=1398312122"